Matsuya R&D

7317.TTSE GROWTH

Filed as Matsuya R&D Co., Ltd (2022-06–2026-06)

Key numbers · FY ended 2026-03

Revenue¥9.8bn+2.1% YoY Operating income¥2.1bn+9.1% YoY Net income (owners)¥1.5bn-0.7% YoY Total assets¥12.5bn+14.7% YoY EPS (basic)¥72.5-1.2% YoY

Full financial history and reports →

Stock price7317 · View chart ↗

Open the price chart on TradingView.

Latest filings

Mon, Jun 29 · JST1 filing

13:045% STAKEMatsuya R&D · OMRON HEALTHCARE Co., Ltd. · 96.41% → 99.98%+3.57pp

Fri, Jun 19 · JST1 filing

16:085% STAKEMatsuya R&D · OMRON HEALTHCARE Co., Ltd. · 14.97% → 96.41%+81.44pp

Thu, Jun 18 · JST1 filing

15:375% STAKEMatsuya R&D · Goto Holding., Co.Ltd. + 4 joint holders · 51.71% → 0.00%−51.71pp

Tue, Jun 16 · JST1 filing

16:04MATERIALMatsuya R&D · Change in major shareholder

Tue, May 19 · JST1 filing

16:05TOBMatsuya R&D · Matsuya R&D Co., Ltd board files opinion on tender offer

All filings →

Major holders (5%+) · 1

Holder	Stake	Change	Filed
OMRON HEALTHCARE Co., Ltd.	99.98%	+3.57pp	2026-06-29

Each holder's own ratio from its most recent large-shareholding report.